| Literature DB >> 22837715 |
Rosivaldo S Borges1,2,3, Auriekson N Queiroz1, Anna P S Mendes1, Sanderson C Araújo2, Luiz C S França1, Edna C S Franco2, Walace G Leal2, Albérico B F Da Silva3.
Abstract
Quantum chemical calculations at the B3LYP/6-31G* level of theory were employed for the structure-activity relationship and prediction of the antioxidant activity of edaravone and structurally related derivatives using energy (E), ionization potential (IP), bond dissociation energy (BDE), and stabilization energies (ΔE(iso)). Spin density calculations were also performed for the proposed antioxidant activity mechanism. The electron abstraction is related to electron-donating groups (EDG) at position 3, decreasing the IP when compared to substitution at position 4. The hydrogen abstraction is related to electron-withdrawing groups (EDG) at position 4, decreasing the BDE(CH) when compared to other substitutions, resulting in a better antioxidant activity. The unpaired electron formed by the hydrogen abstraction from the C-H group of the pyrazole ring is localized at 2, 4, and 6 positions. The highest scavenging activity prediction is related to the lowest contribution at the carbon atom. The likely mechanism is related to hydrogen transfer. It was found that antioxidant activity depends on the presence of EDG at the C(2) and C(4) positions and there is a correlation between IP and BDE. Our results identified three different classes of new derivatives more potent than edaravone.Entities:
Keywords: DFT; antioxidant; bond dissociation energies; edaravone derivatives; ionization potential
Mesh:
Substances:
Year: 2012 PMID: 22837715 PMCID: PMC3397547 DOI: 10.3390/ijms13067594
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Chemical structure and numbering of edaravone.
Figure 2Chemical structure and numbering of edaravone.
Theoretical properties of edaravone and its derivatives.
| Compound | HOMO (eV) | IP (kcal mol−1) | BDECH (kcal mol−1) | Δ |
|---|---|---|---|---|
| −5.73 | 173.0 | 82.1 | 0 | |
| −5.27 | 161.0 | 81.3 | −0.8 | |
| −5.86 | 174.2 | 82.4 | 0.3 | |
| −6.44 | 187.5 | 83.3 | 1.2 | |
| −6.00 | 183.0 | 80.6 | −1.4 | |
| −6.01 | 179.8 | 82.8 | 0.7 | |
| −6.22 | 184.7 | 81.0 | −1.0 | |
| −5.65 | 165.7 | 82.0 | −0.1 | |
| −5.44 | 158.9 | 82.1 | 0 | |
| −6.06 | 174.8 | 81.8 | −0.3 | |
| −5.54 | 166.6 | 81.9 | −0.2 | |
| −5.59 | 165.8 | 81.8 | −0.3 | |
| −5.42 | 162.4 | 82.5 | 0.4 | |
| −5.71 | 169.6 | 83.9 | 1.8 | |
| −5.73 | 170.1 | 82.6 | 0.5 | |
| −5.69 | 170.4 | 75.9 | −6.1 | |
| −5.71 | 169.8 | 73.3 | −8.8 | |
| −5.73 | 171.5 | 74.5 | −7.6 | |
| −5.73 | 173.0 | 83.8 | 1.7 |
Figure 3HOMO conformation of edaravone and its derivatives.
Figure 4LUMO conformation of edaravone and its derivatives.
Figure 5Spin density of cation free-radical of edaravone and its derivatives.
Figure 6Spin density of semiquinone free-radical of edaravone and its derivatives.